top of page
  • Writer's pictureSurviving Breast Cancer

Immunotherapy Response Monitoring in Patients with Breast Cancer



What is Immunotherapy?


Immunotherapy is a type of cancer treatment that seeks to harness the power of the body’s immune system to fight cancer. It works by stimulating or “training” the body’s own natural defense system to recognize and attack cancer cells, essentially giving it the ability to seek out and eliminate tumor cells on its own. Immunotherapy has recently been used in the treatment of metastatic breast cancer (MBC). Examples of breast cancer immunotherapy include monoclonal antibodies, checkpoint inhibitors, cytokine therapy, and adoptive cell therapies.


Monoclonal antibodies are proteins produced in the laboratory that are designed to recognize specific targets on or within cancer cells. They then attach to these targets and either mark the cancer cells for destruction by other parts of the immune system, or directly block signals used by the cancer cells to survive and grow.


Checkpoint inhibitors are drugs that target proteins on T-cells (a type of white blood cell) which prevent them from recognizing and attacking cancer cells. By blocking these proteins, checkpoint inhibitors can help enhance an immune response against breast cancer.


Cytokine therapy is a type of treatment that uses naturally occurring substances in the body called cytokines. Cytokines can be injected into the body to help stimulate an immune response against breast cancer cells and promote tumor regression.


Adoptive cell therapies involve taking T-cells from a patient, modifying them in the laboratory to make them recognize and attach to cancer cells, then infusing them back into the patient. Adoptive cell therapies can help boost an immune response against breast cancer cells and may be useful for treating metastatic disease.


Immunotherapy has emerged as a promising treatment option for many types of cancer, including metastatic breast cancer. However, not all patients respond to immunotherapy, and it can be difficult to monitor the response in those who do receive treatment.


How to know if your treatment is working?


One way to monitor response to immunotherapy in metastatic breast cancer is through imaging studies such as computed tomography (CT) scans or magnetic resonance imaging (MRI). These imaging studies can provide information on tumor size and whether the tumor is shrinking, stable, or growing. However, changes in tumor size may not always be a reliable indicator of response to immunotherapy, as some patients may experience immune-related adverse events that can cause inflammation and swelling around the tumor, leading to an increase in tumor size even if the tumor is responding to treatment.


Another way to monitor response to immunotherapy is through biomarker analysis. Biomarkers are molecular or genetic signatures that can be measured in blood or tissue samples. In the context of immunotherapy, biomarkers such as tumor mutational burden (TMB), programmed death-ligand 1 (PD-L1) expression, and immune cell infiltration can be used to predict response to immunotherapy and monitor response over time.


TMB is a measure of the number of mutations present in a tumor, and tumors with high TMB are more likely to respond to immunotherapy. PD-L1 expression is a marker of immune evasion, and tumors that express high levels of PD-L1 may be more responsive to immunotherapy. Immune cell infiltration, as measured by the density of T cells or other immune cells within the tumor, can also be used to predict response to immunotherapy.


In addition to imaging and biomarker analysis, clinical assessment of symptoms and quality of life can also be used to monitor response to immunotherapy in metastatic breast cancer patients. Patients who are responding to immunotherapy may experience improvements in symptoms such as pain, fatigue, and difficulty breathing, as well as improvements in overall quality of life.


Overall, monitoring response to immunotherapy in the metastatic breast cancer setting requires a multifaceted approach that incorporates imaging studies, biomarker analysis, and clinical assessment of symptoms and quality of life. By using a combination of these methods, clinicians can more accurately assess response to treatment and tailor treatment strategies to individual patients.


What is Signatera?


Recently, a new technology called Signatera has been developed to look for circulating tumor DNA (ctDNA) in the blood of breast cancer patients. CtDNA is a form of genetic material that is shed from cancer cells into the bloodstream and can be used to monitor response to immunotherapy. Signatera uses next-generation sequencing technology to look for mutations in ctDNA that are unique to that patient’s tumor. This technology can be used to detect the presence of ctDNA and track changes in ctDNA over time, which can provide valuable information on response to immunotherapy. Signatera is an exciting new tool that has the potential to revolutionize the way we monitor response to immunotherapy in breast cancer patients. By providing a more accurate assessment of patient response, Signatera could improve clinical outcomes and lead to better treatment decisions for breast cancer patients receiving immunotherapy.


How does Signatera Work?


Signatera is a molecular test that uses ctDNA to monitor response to cancer therapy and detect residual disease in MBC patients undergoing immunotherapy. This technology allows for real-time tracking of the tumor’s genetic signature, allowing clinicians to make decisions about treatment more quickly and accurately than ever before. Signatera can also be used to measure minimal residual disease (MRD), which can predict recurrence or metastasis in MBC patients receiving immunotherapy. By monitoring ctDNA levels, Signatera has the potential to increase accuracy in treatment evaluation, improve patient outcomes and reduce healthcare costs associated with ineffective treatments.


Conclusion


Overall, breast cancer immunotherapy offers an exciting new approach to treating this disease and there are many different treatments available. We also understand that the uncertainty of a breast cancer diagnosis and anxiety of wanting to know if your treatment plan is working is real. Talk to your healthcare provider about which options might be right for you.



You Might Also Like:



SurvivingBreastCancer.org Resources & Support:



309 views

Recent Posts

See All

Kommentare


Meditation Mondays:

Chakra Chanting with Gloria

Mondays at 10:00 a.m. ET 

RSVP

Thursday Night Thrivers:

All Stages Support Group

Thursdays at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Metastatic Breast Cancer Support Group

First and third Thursdays

of the month at 7:00 p.m. ET

RSVP

 

Thursday Night Thrivers:

Inflammatory Breast Cancer Support Group

Second Thursday

of the month at 7:00 p.m. ET

RSVP

Tuesday Night Thrivers

Después de un Diagnóstico:

Grupo de Apoyo en Español

2do y Cuarto Martes de cada mes 

7:00 p.m. ET

RSVP​

Encourage and Empower

For Newly Diagnosed

September 10, 11:00 a.m. ET

RSVP

Breast Cancer Book Club

The first Sunday of the month

RSVP

Pilates

April 12, 10:00 a.m. ET

RSVP

Yoga Stretching for DIEP flap

April 16,  6:00 p.m. ET

RSVP

Restorative Yoga:

The secret Garden

April 22,  6:00 p.m. ET

RSVP

Qi Gong

April 23,  11:30 a.m. ET

RSVP

Art Therapy

May 6, 6:00 p.m. ET

RSVP

Forest Bathing

May 7,  6:00 p.m. ET

RSVP

Reflect & Recharge

Expressive Writing

May 13,  6:00 p.m. ET

RSVP

Yoga Fitness with Chair Assist

May 14, 11:30 a.m. ET

RSVP

Más eventos en español

RSVP

Upcoming Events

1

Surviving Breast Cancer provides breast cancer support, events, and webinars at no cost to you! Whether you are looking to gain more knowledge on a particular topic or meet up with other breast cancer survivors, we have something for everyone. 

2

Our standing appointment on Thursdays is for all stages. We also host specific breakout groups once a month for specific stages and subtypes such as Metastatic breast cancer, and Inflammatory Breast Cancer, etc. 

3

The Book Club meets the first Sunday of every month at 11 am ET. You are welcome to join each month or pick and choose your month based on your availability and the book we are reading. 

4

Through art, writing, and other creative modalities, we hold the power to manage our stress, make sense of our now, and relax into moments of stillness. 

5

Free, monthly, online classes in restorative yoga, yoga for breast cancer, and Zumba. 

6

Después de un Diagnóstico